You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

squamous

Showing 1 - 25 of 7,403
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Head and Neck Squamous Cell Carcinoma
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Oct 25, 2023

Advanced Esophageal Squamous Carcinoma With Oligometastases Trial (simultaneous with radiotherapy, synchronous with

Not yet recruiting
  • Advanced Esophageal Squamous Carcinoma With Oligometastases
  • simultaneous with radiotherapy
  • synchronous with radiotherapy
  • (no location specified)
Nov 16, 2023

Needs and Preferences of Patients With Head-neck Cutaneous SCC

Active, not recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +10 more
  • Regular care with additional administration of a semi-structured interview
  • Maastricht, Netherlands
    Maastricht University Medical Center+
Sep 13, 2023

Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • no intervention
  • Wuhan, Hubei, China
    Renmin hosptial of Wuhan University
Jul 29, 2023

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 30, 2023

Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

Recruiting
  • Esophageal Squamous Cell Carcinoma
    • Shijiazhuang, Hebei, China
      Department of Thoracic Surgery, Fourth Hospital of Hebei Medical
    Oct 25, 2023

    Squamous Cell Cancer, Squamous Cell Carcinoma, Skin Cancer Trial in Boise (30% ascorbic acid in DMSO)

    Recruiting
    • Squamous Cell Cancer
    • +3 more
    • 30% ascorbic acid in DMSO
    • Boise, Idaho
      Center for Biomedical Research,Inc.
    Jul 2, 2023

    Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to

    Active, not recruiting
    • Esophageal Cancer
    • follow up
    • Guangzhou, Guangdong, China
      Jianhua Fu
    Sep 24, 2023

    Patient Perspectives in Squamous Cell Carcinoma Clinical Trials

    Not yet recruiting
    • Squamous Cell Carcinoma
      • San Francisco, California
        Power Life Sciences
      Jun 23, 2023

      Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx

      Not yet recruiting
      • Squamous Cell Carcinoma of the Oral Cavity
      • +3 more
      • Eliminating RT to the elective neck
      • RT standard of care
      • Erlangen, Bavaria, Germany
        Universitätsklinikum Erlangen, Strahlenklinik
      Sep 8, 2023

      Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)

      Not yet recruiting
      • Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
      • Guangzhou, Guangdong, China
        Sun Yat-sen University
      Oct 24, 2023

      Head and Neck Squamous Cell Carcinoma Trial (Carrilizumab, bevacizumab,capecitabine)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Carrilizumab, bevacizumab,capecitabine
      • (no location specified)
      Jul 20, 2023

      Esophageal Squamous Cell Carcinoma Trial (Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin)

      Not yet recruiting
      • Esophageal Squamous Cell Carcinoma
      • Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin
      • (no location specified)
      Aug 17, 2023

      Stage T3 Squamous Cell Carcinomas of the Scalp

      Active, not recruiting
      • Squamous Cell Carcinoma
      • +2 more
        • Maastricht, Netherlands
          Ellen Oyen
        Aug 3, 2023

        Oral Cancer, Oral Squamous Cell Carcinoma Trial in Fayoum (ELISA)

        Recruiting
        • Oral Cancer
        • Oral Squamous Cell Carcinoma
        • ELISA
        • Fayoum, Egypt
          Fayoum University
        Sep 8, 2023

        Cutaneous Squamous Cell Carcinoma Trial (INCB099280)

        Not yet recruiting
        • Cutaneous Squamous Cell Carcinoma
        • (no location specified)
        May 24, 2023

        Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma

        Recruiting
        • Head and Neck Squamous Cell Carcinoma
          • Hangzhou, Zhejiang, China
            Second Affiliated Hospital, School of Medicine, Zhejiang Univers
          Aug 22, 2023

          Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])

          Not yet recruiting
          • Neoplasms
          • +2 more
          • Nivolumab Injection [Opdivo]
          • (no location specified)
          Jul 19, 2023

          Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

          Recruiting
          • Metastatic Esophageal Squamous Cell Carcinoma
          • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
          • Qingdao, Shandong, China
          • +1 more
          Nov 13, 2023

          Oral Squamous Cell Carcinoma, Oral Mucositis Trial in Guangzhou (Alfacalcidol Oral Solution, Placebo)

          Recruiting
          • Oral Squamous Cell Carcinoma
          • Oral Mucositis
          • Alfacalcidol Oral Solution
          • Placebo
          • Guangzhou, Guangdong, China
            Sun Yat-sen Memorial Hospital
          Aug 24, 2023

          Esophageal Cancer, Esophageal Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (LBL-007,

          Not yet recruiting
          • Esophageal Cancer
          • +2 more
          • (no location specified)
          Aug 21, 2023

          Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)

          Not yet recruiting
          • Locally Advanced Head and Neck Squamous Cell Carcinoma
          • (no location specified)
          Mar 20, 2023

          Resectable Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy Trial (cadonilimab+chemo)

          Not yet recruiting
          • Resectable Esophageal Squamous Cell Carcinoma
          • Neoadjuvant Therapy
          • (no location specified)
          Apr 18, 2023

          WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA

          Recruiting
          • Oral Cancer
          • +2 more
          • Biopsy Specimens Histopathology
          • Rawalpindi, Punjab, Pakistan
            Armed Forces Institute of Pathology
          Jun 22, 2023

          Minimal Residual Disease, Esophageal Squamous Cell Carcinoma Trial in Guangzhou

          Not yet recruiting
          • Minimal Residual Disease
          • Esophageal Squamous Cell Carcinoma
            • Guangzhou, Guangdong, China
              Guangdong Provincial People's Hospital
            Jun 10, 2023